Related Experiment Video
Updated: Jun 17, 2026
08:43
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Dementia care: linear links and networks.
Henk Nies1, Julie Meerveld, René Denis
1Centre of Expertise for Long-Term Care, The Netherlands.
Healthcarepapers
|January 9, 2010
Summary
Caring for dementia patients presents significant challenges for primary caregivers, often leading to burnout. New care models, technology integration, and professional collaboration are essential to address this growing social issue.
Area of Science:
- Gerontology
- Neuroscience
- Public Health
Background:
- Dementia poses formidable challenges for patients and their primary caregivers.
- Primary caregivers are at high risk of becoming overburdened, highlighting a significant, under-recognized social issue.
Purpose of the Study:
- To explore new forms of care and support for dementia patients and their caregivers.
- To identify strategies for more goal-oriented dementia care that upholds humane values.
Main Methods:
- The study emphasizes the need for innovative approaches in dementia care.
- It calls for greater integration of technology and a re-evaluation of professional roles.
- Focus on empowering primary care and optimizing the physical and social environments for patients.
Main Results:
- The current approach to dementia care is insufficient to meet the complex needs of patients and caregivers.
- Developing new treatments, interventional care, and technological solutions is crucial.
- Reorganizing professional responsibilities and enhancing primary care are key components.
Conclusions:
- Addressing the challenges of dementia requires a multi-faceted approach, including new care models and technological advancements.
- Optimizing the environment for dementia patients and empowering primary caregivers are critical steps.
- Initiatives in the Netherlands represent a starting point for tackling this complex issue.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...